For over 65 years, ANNEMARIE BRLIND has been creating natural skincare
"But microdosing has not been well studied in clinical trials, and most of the data is anecdotal." She said that when someone asks her about microdosing a GLP-1, she advises that, since it's off-label (meaning not approved by the FDA), carefully monitoring their blood sugar, weight, and symptoms is essential
GI symptoms: Nausea, bloating, constipation, or fatigue are common
This data, combined with traditional biomarkers (HbA1c, BMI, cardiovascular risk markers) and provider clinical judgment, can help you and your healthcare team make a more informed decision about compounded versus branded semaglutide and build a stronger case for coverage